Tag: Surgical Oncology


  • Pembrolizumab Doubles Survival in Advanced Head and Neck Cancer

    Pembrolizumab Doubles Survival in Advanced Head and Neck Cancer

    The Breakthrough: A New Immunotherapy Redefines Outcomes in Locally Advanced Head and Neck Cancer Locally advanced head and neck cancer poses a formidable challenge. In many patients, the disease is detected at a stage where surgery, radiotherapy, and chemotherapy are the mainstays of treatment, yet recurrence and progression remain common. A recent advance in immunotherapy,…